HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 -- Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1...

Join Visiopharm at USCAP 2017 and learn about how we are transforming pathology! Come see demonstrations of Analysis of PD-L1 and CD Markers within the Tumor Micro-Environment Visualize and quantify biomarker expression with heatmaps...

Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com.  It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More...

New applications on the platform enable acceleration of breakthroughs in the fight against cancer. Baltimore, MD; San Diego, CA (PRWEB) October 24, 2016 -- Proscia Inc, the industry's leading provider of cloud solutions for digital...

Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School  Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...

More interesting news around PD-L1 for use in Classical Hodgkin lymphoma with specific indications as below. Another increasingly common example of companion diagnostics and personalized immunotherapies. On May 17, 2016, the U.S. Food and Drug...